When.com Web Search

  1. Ads

    related to: bausch and lomb ophthalmic samples for physicians group associates

Search results

  1. Results From The WOW.Com Content Network
  2. ISTA Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Ista_Pharmaceuticals

    ISTA Pharmaceuticals, Inc., was a US-based pharmaceutical company that specialized in ophthalmic pharmaceutical products and discovers, develops, and markets therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. [1] ISTA was acquired by Bausch & Lomb, an eye care company, on March 26, 2012. [2] Under the deal, Bausch & Lomb ...

  3. Bausch & Lomb - Wikipedia

    en.wikipedia.org/wiki/Bausch_&_Lomb

    Bausch & Lomb (since 2010 stylized as Bausch + Lomb [2]) is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses , [ 3 ] lens care products, pharmaceuticals, intraocular lenses , and other eye surgery products.

  4. Loteprednol - Wikipedia

    en.wikipedia.org/wiki/Loteprednol

    Loteprednol (synthesized as the ester loteprednol etabonate) is a topical corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax [2] and Loterex. It was patented in 1980 and approved for medical use in 1998. [3] It is available as a generic medication. [4]

  5. You might think they’re Bausch & Lomb eye drops. The ... - AOL

    www.aol.com/might-think-bausch-lomb-eye...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Valeant Pharmaceuticals to Buy Bausch & Lomb for $8.7 ... - AOL

    www.aol.com/news/2013-05-27-valeant-pharamace...

    By Euan Rocha and Rod Nickel TORONTO -- Valeant Pharmaceuticals International said on Monday it agreed to buy Bausch & Lomb Holdings Inc from Warburg Pincus LLC for $8.7 billion in cash, a deal ...

  7. Bausch Health's Eye-Care Spin-Off Entity Files For $100M IPO

    www.aol.com/bausch-healths-eye-care-spin...

    Bausch & Lomb Corp filed S-1 for its initial public offering, nearly 1.5 years after its parent company, Bausch Health Companies Inc (NYSE: BHC) said it would spin off the eye-care company. The ...

  1. Ad

    related to: bausch and lomb ophthalmic samples for physicians group associates